Central nervous system pharmacology of neuropeptide Y
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 65 (3), 397-414
- https://doi.org/10.1016/0163-7258(95)98598-k
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Is PP56 (D-myo-inositol-1, 2, 6-triphosphate) an antagonist at neuropeptide Y receptors?Life Sciences, 1993
- Centrally administered neuropeptide Y fails to increase food intake but enhances hypoalgesia in spontaneously hypertensive ratsNeuroscience Letters, 1993
- Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YYLife Sciences, 1992
- Centrally injected neuropeptide Y (13–36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1–36) in the awake male ratNeuroscience Letters, 1990
- Inhibitory effects of neuropeptide Y on cyclic AMP accumulation in slices of the nucleus tractus solitarius region of the ratNeuroscience Letters, 1987
- 2-amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepamLife Sciences, 1986
- Neuropeptide Y in the intermediate lobe of the frog pituitary acts as an α-MSH-release inhibiting factorLife Sciences, 1986
- Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: Immunohistochemical evidenceNeuroscience Letters, 1986
- Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's diseaseNeuroscience Letters, 1986
- Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neuronsNeuroscience Letters, 1984